Provided by Tiger Trade Technology Pte. Ltd.

Celsion

1.96
0.0000
Volume:- -
Turnover:133.13K
Market Cap:13.91M
PE:-0.46
High:1.96
Open:1.96
Low:1.96
Close:1.96
52wk High:15.75
52wk Low:1.80
Shares:7.10M
Float Shares:6.99M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3047
EPS(LYR):-3.8271
ROE:-47.07%
ROA:-18.85%
PB:0.30
PE(LYR):-0.51

Loading ...

Company Profile

Company Name:
Celsion
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.